Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Bio.X2Y
    Member
    • Apr 2010
    • 46

    #1

    HG19 Unlocalized Contigs

    Hi,

    I was wondering if someone might be able to shed some light on the "validity" of the unlocalized contigs that are included as part of the UCSC HG19 assembly (not the haplotypes).

    In particular, do these contigs reflect:
    (a) chromosome segments that are definitely known to exist, and are not already present on the traditional chromosomes, and will in time get localised.
    (b) segments that may or may not exist (e.g. their apparent existence might be an artifact of the assembly process), and so may never be localised.

    I'm asking because I'm trying to get a feeling for whether it is appropriate to include these in an rna-seq mapping exercise.

    Thanks!
  • NextGenSeq
    Senior Member
    • Apr 2009
    • 482

    #2
    I don't think anyone knows for sure but I vote for a

    Also, some are mitochondrial DNA.

    Comment

    • vinay052003
      Member
      • Jan 2010
      • 59

      #3
      By definition these contigs are "yet to be placed" fragments of the chromosomes. These contigs possibly arise from highly repetitive regions such as centromere or other highly variable places in the genome (due to transposable elements and sites of high recombination rate). These contigs have gene annotation tracks and other kinds of annotations similar to well mapped chromosomal sequences. So I guess there is no harm in including these sequences while mapping sequencing reads.

      Comment

      • Brugger
        Member
        • Mar 2010
        • 21

        #4
        Just to clarify things: There are two different classes of non-placed clones in GRCh37 (the official name, not hg19, as ucsc calls it).

        Unplaced: with means that is it known what chromosome a clone belongs to, but cannot be placed in the TPF with confidence. The mapping to chromosomes was done in various ways including FISH.

        Unlocalized: which means that they belong to the human genome, but to what chromosome they belong is yet to be established. These include clones with repeated regions that can go to multiple chromosomes. I seem to recall that the chr22-p clones went there because the region is so repetitive.

        So to answer your question, the clones are placed in these two classes until they can be placed correctly in the TPF and included in the genome. The goal of the GRC (Genome Reference Consortium), is improve the human assembly now that the sequencing technology has improved.

        As far as I know (I used to be part of GRC) there is no mitochondrial DNA in the unplaced/unlocalized clones, if you find any please report this to the GRC: http://www.ncbi.nlm.nih.gov/projects.../contact.shtml

        Comment

        • freeseek
          Junior Member
          • Feb 2010
          • 8

          #5
          HG19 Unlocalized Contigs

          Brugger, could you shed some light on why some contigs are unplaced and some are unlocalized? Where they all analyzed using FISH? And if so, why most of them were not placed? Is there any reference that correctly explains how these contigs were handled?

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          23 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          27 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-13-2026, 09:56 AM
          0 responses
          23 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-09-2026, 11:14 AM
          0 responses
          28 views
          0 reactions
          Last Post SEQadmin2  
          Working...